drugset / Trial / NCT07133399

A Study in Healthy People to Test How 2 Different Formulations of a Combination Treatment (Vicadrostat and Empagliflozin) Are Taken up in the Body and How Food Influences the Amount of the Medicines in the Blood

NCT07133399

Phase 1 Completed 32 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

To investigate the relative bioavailability of two different vicadrostat/empagliflozin combinations. Additionally, the trial investigates the effect of food on the pharmacokinetics of the vicadrostat/empagliflozin.

Timeline

Start
2025-09-08
Primary completion
2025-10-22
Completion
2025-10-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Empagliflozin Small molecule
Subject Vicadrostat Small molecule

Indications

No indication recorded.